百克生物
(688276)
| 流通市值：93.36亿 | | | 总市值：159.47亿 |
| 流通股本：2.42亿 | | | 总股本：4.14亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 270,288,441.14 | 1,824,688,777.32 | 1,243,193,321.15 | 559,644,250.74 |
| 营业收入 | 270,288,441.14 | 1,824,688,777.32 | 1,243,193,321.15 | 559,644,250.74 |
| 二、营业总成本 | 210,708,743.52 | 1,183,601,579.38 | 832,335,257.4 | 429,628,760.77 |
| 营业成本 | 27,791,407.74 | 178,215,317.38 | 138,909,195.35 | 67,017,968.08 |
| 税金及附加 | 2,236,863.14 | 13,042,235.9 | 8,981,205.55 | 4,921,469.71 |
| 销售费用 | 99,954,306.04 | 647,168,906.88 | 443,839,637.23 | 211,353,736.41 |
| 管理费用 | 35,236,273.09 | 159,344,714.38 | 114,464,776.03 | 68,136,010.68 |
| 研发费用 | 46,940,335.5 | 198,074,582.76 | 136,687,474.68 | 86,605,757.27 |
| 财务费用 | -1,450,441.99 | -12,244,177.92 | -10,547,031.44 | -8,406,181.38 |
| 其中:利息费用 | 499,125.92 | 704,969.33 | 556,628.83 | 263,946.27 |
| 其中:利息收入 | 1,869,238.91 | 12,443,555.45 | 10,376,659.63 | 7,848,216.1 |
| 加:投资收益 | 266,749.21 | 689,968.27 | 465,764.64 | 314,078.76 |
| 资产处置收益 | - | 20,771.77 | - | - |
| 资产减值损失(新) | - | -55,212,527.99 | -14,186,037.54 | 1,822,768.46 |
| 信用减值损失(新) | 3,390,206.81 | -31,718,830.05 | -29,848,958.32 | -18,862,420.75 |
| 其他收益 | 1,026,010.46 | 4,424,444.6 | 2,425,021.25 | 1,367,163.46 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 64,262,664.1 | 559,291,024.54 | 369,713,853.78 | 114,657,079.9 |
| 加:营业外收入 | 226.97 | 8,513,940.52 | 7,112,526.48 | 6,912,526.48 |
| 减:营业外支出 | 131,238.24 | 4,049,860.44 | 3,337,408.21 | 2,451,961.31 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 64,131,652.83 | 563,755,104.62 | 373,488,972.05 | 119,117,645.07 |
| 减:所得税费用 | 3,566,587.4 | 62,745,922.23 | 42,395,782.84 | 7,734,204.64 |
| 六、净利润 | 60,565,065.43 | 501,009,182.39 | 331,093,189.21 | 111,383,440.43 |
| 持续经营净利润 | 60,565,065.43 | 501,009,182.39 | 331,093,189.21 | 111,383,440.43 |
| 归属于母公司股东的净利润 | 60,565,065.43 | 501,009,182.39 | 331,093,189.21 | 111,383,440.43 |
| (一)基本每股收益 | 0.15 | 1.21 | 0.8 | 0.27 |
| (二)稀释每股收益 | 0.15 | 1.21 | 0.8 | 0.27 |
| 八、其他综合收益 | -7,585,178.55 | -20,904,871.43 | -11,430,343.25 | -3,481,235.23 |
| 归属于母公司股东的其他综合收益 | -7,585,178.55 | -20,904,871.43 | -11,430,343.25 | -3,481,235.23 |
| 九、综合收益总额 | 52,979,886.88 | 480,104,310.96 | 319,662,845.96 | 107,902,205.2 |
| 归属于母公司股东的综合收益总额 | 52,979,886.88 | 480,104,310.96 | 319,662,845.96 | 107,902,205.2 |
| 公告日期 | 2024-04-20 | 2024-03-20 | 2023-10-24 | 2023-08-24 |
| 审计意见(境内) | | 标准无保留意见 | | |